JULY 2, 2024 by Cell Press Acute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public Domain Researchers show for the first time that engineered human plasma B cells can be used to treat a disease—specifically leukemia—in a humanized animal model. The results mark a key step in the realization of ePCs as therapies to treat cancer, auto-immune...
